Archives
-
Biotin-Tyramide for TSA and Proximity Labeling
2026-08-27
Biotin-tyramide is an HRP-responsive biotinylation reagent for spatial signal amplification in fixed-cell imaging, immunohistochemistry, and in situ hybridization. Its biotin phenol-like radical chemistry supports localized deposition that can be read with streptavidin-based fluorescence or chromogenic systems.
-
1-methyl Adenosine: From RNA Mark to Biomarker
2026-08-27
Explore how 1-methyl Adenosine and 1-methyl Ado connect RNA turnover with cancer metabolism studies, biomarker discovery, and better quantitative assay design.
-
28S rRNA Expansion Segments Build Nucleolar Layers
2026-08-26
Wei and colleagues show that 28S rRNA expansion segments act as multivalent architectural elements that can reconstitute layered nucleolar-like structures. Their combination of cellular localization, in vitro assembly, comparative species analysis, targeted deletion, segment transfer, and simulation connects evolutionary RNA expansion with nucleolar complexity.
-
Bradykinin BA5201: Practical Research Guide
2026-08-26
Bradykinin (BA5201) provides a research peptide for controlled studies of endothelium-dependent vasodilation, vascular permeability, smooth muscle contraction, pain mechanisms, and inflammatory responses. It is intended for laboratory use only; the dossier does not support diagnostic, clinical, or therapeutic applications, and assay-specific concentrations and exposure conditions must be established by the researcher.
-
1-methyl Adenosine: Workflow and Assay Guide
2026-08-25
Build cleaner 1-methyl Adenosine experiments by combining controlled cell exposure, matrix-aware extraction, and isomer-resolved UHPLC–MS/MS. The workflow supports RNA modification research, cancer metabolism studies, biomarker discovery, and carefully controlled therapeutic target validation.
-
L. gasseri ATCC33323, NR1I3, and Colitis Barrier
2026-08-25
The reference study identifies an E-cadherin-centered mechanism by which Lactobacillus gasseri ATCC33323 reduces DSS-induced colitis in mice. Its combination of intestinal E-cadherin perturbation, transcriptional analysis, and in vitro validation connects probiotic treatment with NR1I3-mediated regulation of CDH1, while also highlighting the limits of translating a chemical injury model into human inflammatory bowel disease.
-
CasKAS: Genome-Wide CRISPR Specificity by ssDNA Mapping
2026-08-24
CasKAS introduces a chemical ssDNA-mapping strategy for profiling genome-wide Cas9 and dCas9 binding specificity. By detecting the unwound DNA created when an sgRNA-loaded CRISPR enzyme engages a target, the method provides a rapid and comparatively accessible complement to cleavage- and occupancy-based assays.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Workflow Guide
2026-08-24
ARCA Cy3 EGFP mRNA (5-moUTP) combines direct Cy3 tracking with EGFP reporter expression, allowing researchers to separate cellular uptake from productive translation. This guide presents practical workflows for mammalian-cell delivery studies, formulation benchmarking, localization assays, and troubleshooting.
-
PLAC1 Targeting in Clear Cell Renal Cell Carcinoma
2026-08-23
A 2025 study identifies PLAC1 as both a prognostic biomarker and a candidate molecular target in clear cell renal cell carcinoma. By combining TCGA analysis, protein-level validation, PLAC1 knockdown, and high-throughput virtual screening, the authors nominate Amaronol B and canagliflozin for experimental follow-up.
-
Tetracycline Hydrochloride: Applied Workflows
2026-08-22
Build more reproducible bacterial growth, translation, and microbiome experiments with Tetracycline Hydrochloride. This guide emphasizes formulation control, bacteriostatic-versus-bactericidal readouts, and a carefully bounded comparison with rapid ROS-driven cancer assays.
-
O-propargyl-puromycin (OPP) for Translation Assays
2026-08-21
Learn how O-propargyl-puromycin (OPP), SKU A8778, separates nascent protein synthesis from viability and metabolic readouts in cell-based assays. This scenario-driven guide covers assay design, click-chemistry compatibility, optimization, interpretation, and practical reagent selection.
-
Neomycin Sulfate: Designing Mechanistic Assays
2026-08-21
Neomycin sulfate is more than an aminoglycoside antibiotic: it is a context-dependent probe for RNA, DNA, and ion-channel mechanisms. This guide shows how to convert its distinct binding and blocking behaviors into better-controlled assays, while extracting practical lessons from microbiome and immunology research.
-
Neuritin, ER Stress, and NF-κB After SAH
2026-08-20
This study identifies endoplasmic reticulum stress-related inflammatory pathways as an important mechanistic link between subarachnoid hemorrhage and early brain injury. It further shows that neuritin overexpression suppresses convergent NF-κB signaling, reducing neuroinflammation and neuronal apoptosis, although translation beyond the experimental SAH setting requires additional validation.
-
1-methyl Adenosine for RNA Quantification
2026-08-20
Use 1-methyl Adenosine as both a defined reagent for mechanistic experiments and a measurable endpoint of RNA turnover. A stable isotope-diluted UHPLC–MS/MS workflow adds isomer resolution, matrix control, and biomarker-ready sensitivity for RNA modification research, cancer metabolism studies, and disease-model comparison.
-
Ribonuclease R: A Topology Test for circRNA
2026-08-19
Ribonuclease R, supplied as RNase R (20 U/μL), can do more than enrich circular RNA. This article presents a topology-aware assay strategy for testing circRNA identity and interpreting inflammation-linked mechanisms such as the circ_0042103/TAF15/NER axis.